Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2239 | 2019 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 531 | 2019 |
Controversies in endocrinology: On the need for universal thyroid screening in pregnant women L Vila, I Velasco, S González, F Morales, E Sánchez, S Torrejon, ... European journal of endocrinology 170 (1), R17-R30, 2014 | 79 | 2014 |
Insulin use and excess fracture risk in patients with type 2 diabetes: a propensity-matched cohort analysis E Losada-Grande, S Hawley, B Soldevila, D Martinez-Laguna, X Nogues, ... Scientific Reports 7 (1), 3781, 2017 | 59 | 2017 |
Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case–control study E Losada, B Soldevila, MS Ali, D Martínez-Laguna, X Nogués, ... Osteoporosis international 29, 2079-2086, 2018 | 51 | 2018 |
Impact of TSH during the first trimester of pregnancy on obstetric and foetal complications: usefulness of 2.5 mIU/L cut‐off value M Hernández, C López, B Soldevila, L Cecenarro, M Martínez‐Barahona, ... Clinical Endocrinology 88 (5), 728-734, 2018 | 43 | 2018 |
Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma JL Reverter, E Colomé, S Holgado, E Aguilera, B Soldevila, L Mateo, ... Endocrine 37, 467-472, 2010 | 35 | 2010 |
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease A Palanca, E Castelblanco, À Betriu, H Perpiñán, B Soldevila, ... Cardiovascular Diabetology 18, 1-9, 2019 | 33 | 2019 |
Hypothyroidism during pregnancy and its association to perinatal and obstetric morbidity: a review M Martínez, B Soldevila, A Lucas, I Velasco, L Vila, M Puig-Domingo Endocrinología, Diabetes y Nutrición (English Ed.) 65 (2), 107-113, 2018 | 33 | 2018 |
Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study N Alonso, ML Granada, B Soldevila, I Salinas, C Joaquin, JL Reverter, ... Journal of endocrinological investigation 34, 340-344, 2011 | 33 | 2011 |
Regulatory T cells in diabetes and gastritis N Alonso, B Soldevila, A Sanmartí, R Pujol-Borrell, E Martínez-Cáceres Autoimmunity Reviews 8 (8), 659-662, 2009 | 33 | 2009 |
Pasireotide in the personalized treatment of acromegaly M Puig-Domingo, I Bernabéu, A Picó, B Biagetti, J Gil, C Alvarez-Escolá, ... Frontiers in Endocrinology 12, 648411, 2021 | 30 | 2021 |
Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes A Palanca, E Castelblanco, H Perpiñán, À Betriu, B Soldevila, ... Atherosclerosis 276, 50-57, 2018 | 30 | 2018 |
A prospective study of T‐ and B‐lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in … B Soldevila, N Alonso, MJ Martínez‐Arconada, RM Morillas, R Planas, ... Journal of viral hepatitis 18 (6), 384-392, 2011 | 30 | 2011 |
Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population E Aguilera, E Serra-Planas, ML Granada, S Pellitero, JL Reverter, ... Cardiovascular diabetology 14, 1-7, 2015 | 27 | 2015 |
Impact of COVID-19 on nutritional status during the first wave of the pandemic A Ramos, C Joaquin, M Ros, M Martin, M Cachero, M Sospedra, ... Clinical nutrition 41 (12), 3032-3037, 2022 | 26 | 2022 |
High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with Type 1 Diabetes Mellitus from a Mediterranean area E Serra-Planas, E Aguilera, ML Granada, B Soldevila, I Salinas, ... Acta Diabetologica 52, 773-779, 2015 | 25 | 2015 |
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? B Soldevila, M Puig-Domingo, M Marazuela Reviews in Endocrine and Metabolic Disorders 23 (2), 137-150, 2022 | 24 | 2022 |
Asistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014 D Acosta, M Balsells, M Ballesteros, MO Bandres, JL Bartha, J Bellart, ... Avances en Diabetología 31 (2), 45-59, 2015 | 24 | 2015 |
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study MT Julián, G Pera, B Soldevila, L Caballería, J Julve, C Puig-Jové, ... European Journal of Endocrinology 184 (4), 587-596, 2021 | 21 | 2021 |